In 1984, William C. Roberts, MD (1), wrote of exercise training as the "wonder drug" that treated a host of conditions affecting cardiac patients, including patients with heart failure (HF) with reduced ejection fraction. Subsequent studies in patients with HF with reduced ejection fraction identified that exercise training improved central transport, regional blood flow, the autonomic nervous system, skeletal muscle physiology, and vasculature reactivity. These benefits have been shown to translate into improved quality of life for patients with HF with reduced ejection fraction. Unfortunately, significantly reducing mortality and hospitalizations has been more difficult to achieve (2, 3) .
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Although smaller studies have identified a signal suggesting a mortality benefit, the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) study found no mortality benefit but was able to identify a significant decrease in all-cause mortality or all-cause hospitalization, with an 11% decrease in risk, only after adjusting for baseline characteristics strongly predictive of the outcome (4) .
A distinguishing feature of trials in this area has been the duration of the exercise intervention, with only a handful of studies evaluating training protocols beyond 12 months (4 -7). In this issue of the Journal, Belardinelli et al. (8) provide the results of a 10-year exercise intervention, which can be viewed as a follow-up study to the first study performed by the group (7). The intervention was split into 2 phases: a supervised phase for 12 months based on the original study (3 sessions per week for 2 months, then 2 supervised sessions the rest of the year) and a communitybased intervention, the "coronary club," that promoted exercise training and healthy lifestyle changes. Patients participating in the intervention exercised 176 times per year (supervised and at home) with the club in what is described by the investigators in the discussion as supervised sessions, with no quantification of activity outside the club provided. The intensity of the exercise prescription was individualized on the basis of the results of a cardiopulmonary exercise test. Patients in the usual-care arm received similar lifestyle education before randomization, including an education manual, and were advised to remain active but to avoid high-intensity exercise. On average, patients in the nontraining arm of the study performed physical activity 2 Ϯ 3 times per week.
The intervention provided in this study improved all of the outcomes collected in a staggered fashion. As seen in previous studies, including HF-ACTION (4,9), functional capacity and quality of life for patients in the training intervention improved over the first 12 months, with a sustained yet unchanging benefit over subsequent years. It took 5 years to identify a difference in left ventricular ejection fraction. Steady reductions in cardiac death and HF hospitalizations followed these trends over the 10 years of the study, reaching significance at the end of the study.
As noted by the investigators in discussing the study limitations, the reduction in clinical events must be considered cautiously given the sample size, the baseline treatment of these patients, and the mortality rate observed in the cohort. The study was designed to detect a difference in functional capacity, not to detect a difference in mortality. Although it is well known that smaller sample size increases the risk for a type II error (not rejecting the null hypothesis when there is a difference), underpowered studies also increase the risk for false-positive results (10, 11) . Although all of the patients were on either angiotensin-converting enzyme inhibitors or angiotensin blockers, the use of betablockers (46%) and implantable cardioverter-defibrillators (7%) was at levels significantly lower than those observed in HF-ACTION (94% for beta-blockers and 40% for implantable cardioverter-defibrillators). Given the proven benefit of these treatments in patients with HF (12), it is unlikely that the present study would have achieved such a large risk reduction as detected in this cohort. Finally, despite the underutilization of evidence-based therapy, the overall mortality rate over 10 years (12% for the overall cohort) raises some questions about the level of risk in the present cohort. We have recently read in this journal about the risks of relying on small studies to evaluate the effect of treatments (13) .
The investigators should be congratulated for the remarkable adherence that the present study achieved (88% over the study period). The study provides some valuable lessons regarding adherence, which has been a longstanding issue for exercise training studies enrolling patients with HF (14) . This was achieved primarily through supervised training both at the hospital and within the coronary club over 10 years. Patients with HF have a difficult time remaining adherent to an exercise training regimen at home by themselves. In both the HF-ACTION study and the Exercise Rehabilitation Trial, which included home-based exercise after an initial phase of supervised training, adherence to the recommended exercise regimen at home was approximately 60% (4,15), which is not dissimilar to healthy subjects over 12 months (16) . Most single-center studies, including the present study, have incorporated supervised training as the primary strategy for achieving high adherence rates. This strategy can be easily incorporated into the modern cardiac rehabilitation model used in the treatment of patients, but providing this level of supervision over 10 years, or even 12 months as done in the previous study, would be difficult to implement, in terms of both feasibility and cost (17) . The group interactions and dynamics created by the coronary club is one strategy that has worked in the past for patients with HF and seems to have played a role in the high compliance rate in the present study. Social support, from family members, friends, or other patients, has been associated with improved exercise adherence in older adults (18) . It is not surprising to see the benefit of group or social support on exercise adherence, because it has been identified with greater medication adherence (19) . Other strategies that improve adherence that can be integrated into group programs include goal setting and feedback, such as pedometers or exercise test results (14) .
When the additional interactions with the supervising cardiologist and exercise physiologists and the educational focus of the coronary club are taken into account, one has to question if this was a study of exercise training or a study evaluating a disease management strategy or model of health care delivery outside the hospital that includes exercise training as a core component. Disease management strategies, including patient education, have been shown to improve clinical outcomes for patients (20) . It is difficult to isolate the benefit of exercise training in studies incorporating established programs such as cardiac rehabilitation or community programs, which traditionally provide other resources to patients.
Instead of shying away from the reality that training interventions are more than just exercise, investigators need to better define the totality of the intervention being provided. Gravitating toward a more rigorous method for presenting these interventions and implementing a taxonomy, similar to the recommendation put forth for disease management, will help clarify the additional components of these multifaceted interventions (21) and allow providers a better opportunity to replicate the interventions in their communities. 
